ATE87480T1 - 4-chinolincarbon-derivate, brauchbar als immuno- suppressive wirkstoffe. - Google Patents

4-chinolincarbon-derivate, brauchbar als immuno- suppressive wirkstoffe.

Info

Publication number
ATE87480T1
ATE87480T1 AT89107099T AT89107099T ATE87480T1 AT E87480 T1 ATE87480 T1 AT E87480T1 AT 89107099 T AT89107099 T AT 89107099T AT 89107099 T AT89107099 T AT 89107099T AT E87480 T1 ATE87480 T1 AT E87480T1
Authority
AT
Austria
Prior art keywords
quinolinecarbone
immuno
derivatives useful
suppressive agents
useful
Prior art date
Application number
AT89107099T
Other languages
English (en)
Inventor
Neil Richard Ackerman
Bruce Donald Jaffee
Scott Edward Loveless
Russell Howard Neubauer
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Application granted granted Critical
Publication of ATE87480T1 publication Critical patent/ATE87480T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT89107099T 1988-04-26 1989-04-20 4-chinolincarbon-derivate, brauchbar als immuno- suppressive wirkstoffe. ATE87480T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/186,243 US4968701A (en) 1988-04-26 1988-04-26 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
EP89107099A EP0339485B1 (de) 1988-04-26 1989-04-20 4-Chinolincarbon-Derivate, brauchbar als immuno-suppressive Wirkstoffe

Publications (1)

Publication Number Publication Date
ATE87480T1 true ATE87480T1 (de) 1993-04-15

Family

ID=22684181

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89107099T ATE87480T1 (de) 1988-04-26 1989-04-20 4-chinolincarbon-derivate, brauchbar als immuno- suppressive wirkstoffe.

Country Status (13)

Country Link
US (1) US4968701A (de)
EP (1) EP0339485B1 (de)
JP (1) JP2650757B2 (de)
KR (1) KR0134376B1 (de)
AT (1) ATE87480T1 (de)
CA (1) CA1333155C (de)
DE (1) DE68905642T2 (de)
DK (1) DK170414B1 (de)
IE (1) IE64760B1 (de)
IL (1) IL90055A (de)
MY (1) MY106038A (de)
PT (1) PT90363B (de)
ZA (1) ZA893087B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US5135934A (en) * 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
MX9200299A (es) * 1991-02-07 1992-12-01 Roussel Uclaf Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
US6004979A (en) * 1991-02-07 1999-12-21 Hoechst Marion Roussel Nitrogenous bicycles
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US6194376B1 (en) 1991-03-11 2001-02-27 Creative Biomolecules, Inc. Method for modulating inflammatory response comprising administering morphogen
TW232013B (de) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
EP0830133A1 (de) * 1995-04-28 1998-03-25 Takeda Chemical Industries, Ltd. Therapeutische zusammensetzung für arthritis
AU2896097A (en) * 1996-05-10 1997-12-05 Novartis Ag Use of brequinar and derivatives in chronic rejection of allografts and xenotransplantation
DK0825186T3 (da) * 1996-08-16 2002-07-22 Pfizer 2-aminobenzazepinderivater og deres anvendelse til behandling af immunosuppression
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU757059B2 (en) 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU2108099A (en) * 1998-01-30 1999-08-16 Procept, Inc. Immunosuppressive agents
CN101056540A (zh) 2004-09-27 2007-10-17 诺维信公司 酶颗粒
WO2015077535A2 (en) 2013-11-22 2015-05-28 Genzyme Corporation Novel methods for treating neurodegenerative diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6592M (de) * 1967-10-31 1968-12-30
GB1334705A (en) * 1970-06-19 1973-10-24 Ici Ltd Pharmaceutical compositions containing kynurenic acid derivatives
CH576447A5 (de) * 1972-03-10 1976-06-15 Ciba Geigy Ag
US4407803A (en) * 1981-08-17 1983-10-04 Abbott Laboratories Antiinflammatory 1-(quinolinyl)-2-pyrazoline derivatives
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4847381A (en) * 1987-08-31 1989-07-11 American Cyanamid Company 2-Phenyl-4-quinoline carboxylic acids

Also Published As

Publication number Publication date
IL90055A (en) 1993-05-13
PT90363B (pt) 1994-08-31
CA1333155C (en) 1994-11-22
IL90055A0 (en) 1989-12-15
AU628045B2 (en) 1992-09-10
MY106038A (en) 1994-03-31
DE68905642D1 (de) 1993-05-06
IE891328L (en) 1989-10-26
DE68905642T2 (de) 1993-08-12
EP0339485A1 (de) 1989-11-02
KR900016137A (ko) 1990-11-12
IE64760B1 (en) 1995-09-06
DK200289A (da) 1989-10-27
AU3332189A (en) 1989-11-02
PT90363A (pt) 1989-11-10
JPH01313428A (ja) 1989-12-18
ZA893087B (en) 1990-12-28
KR0134376B1 (ko) 1998-04-21
DK170414B1 (da) 1995-08-28
JP2650757B2 (ja) 1997-09-03
EP0339485B1 (de) 1993-03-31
US4968701A (en) 1990-11-06
DK200289D0 (da) 1989-04-25

Similar Documents

Publication Publication Date Title
DE68905642D1 (de) 4-chinolincarbon-derivate, brauchbar als immuno-suppressive wirkstoffe.
OA07116A (fr) Esters aromatiques hétérocycliques de stéroïdes, leur préparation et compositions pharmaceutiques les contenant.
EP0936217A4 (de) 1-phenylpyrozol-verbindungen und ihre medizinische anwendung
SE7903186L (sv) Cerebralverksamt medel
DK653688A (da) Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
FI883249A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
ATE50255T1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro7h-pyrido(1,2,3-de>(1,4>benzoxazin-6-carbonsaeur ; substituierte 5-amino-6-fluor-1,4-dihydro-4-oxochinolin-3-carbons|ure; substituierte 5-amino-6fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3- carbonsaeure; ihre derivate; diese enthaltende pharmazeutische zubereitungen und verfahren
EP0537191A4 (en) Treatment of organ transplantation rejection
NO179671C (no) Substituerte cykloheksanderivater, anvendelse av disse for fremstilling av legemidler samt legemiddel for behandling type II diabetes og andre sykdommer
RU93045145A (ru) Замещенные производные циклогексана и их применение для лечения заболеваний, содержащее их лекарственное средство
DE3860201D1 (de) Entzuendungshemmende agentien.
MA22495A1 (fr) Derives d'amidinophenylalanine, procede pour leur preparation et leur utilisation
FI891986A0 (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
NO882238D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
NO172537C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater
ATE85891T1 (de) Verwendung von omega-3-fettsaeuren als antikachexiemittel.
FI880385A0 (fi) Substituerade 3-fenyl-7h-tiazolo /3,2-b//1,2,4/-triazin-7-oner, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning, samt naogra vid framstaellningen av naemnda foereningar bildade mellanprodukter.
FI925546A7 (fi) Amidiliittyneitä pyridyylihappojohdannaisia leukotrieeniin liittyvien sairauksien hoitamiseksi
ATE107648T1 (de) 1-carbacephalosporin-antibiotika.
ITMI920539A0 (it) Procedimento per la separazione dell'acido ftalimmido perossicaproico da soluzioni di solventi organici
ATE137503T1 (de) (1's)-hydroxyalkyloxapenem-3-carbonsäuren und ihre verwendung als betalactamasehemmer
IT1183890B (it) Dispositivo di impianto per il trattamento chirurgico dell'infertilita da ostruzione tubarica
FI882388A0 (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
IT8720701A0 (it) Composizioni farmaceutiche adattivita' immunomodulante.
ITMI911206A0 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari